Watch Ticker

BeiGene, Ltd. American Depositary Shares

Go to BeiGene, Ltd. American Depositary Shares Website

$304.30

5.29 (1.77%)

Live

Previous Close

$299.01

Day Range

$298.7 - $305.225

Previous Day Range

$288.072 - $299.29

Market Cap

$32.4 billion USD

Day Vol.

348664

Previous Day Vol.

543061

Currency

USD

Primary Exchange

None

Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeiGene is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract ...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Zymeworks Inc. - Zymeworks to Report Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025

Zymeworks, a clinical-stage biotechnology company, will report its Q2 2025 financial results on August 7, 2025, and participate in upcoming investor conferences. The company has received regulatory approvals for zanidatamab, a HER2-targeted bispecific antibody for biliary tract cancer treatment.

Related tickers: ZYME, ONC, JAZZ.

Read Full Article

Delveinsight - Waldenstrom Macroglobulinemia Market Sees Surging Demand Across the 7MM Amid BTK Inhibitor Advancements | DelveInsight

The Waldenstrom macroglobulinemia market is experiencing steady growth driven by advances in targeted therapies, particularly BTK inhibitors. Rising awareness, improved diagnostics, and increasing clinical trials are propelling market expansion, with several emerging drugs showing promise in treating this rare lymphoma.

Related tickers: CLRB, BGNE, ONC, MRK, NRIX.

Read Full Article

Trending Tickers

Please sign in to view